Explorer les evidences

9,7 %Surveillance drug resistance mutations (SDRMs) were observed in 36 of 373 ART-naive participants (9.7%) from March 2013 to June 2017 in Lagos and Abuja, Nigeria.

NigeriaVIH/sidaobservé March 2013 to June 2017publié 2019Antiviral therapyPubMeddocument de 6 observations

11,1 %11.1% of participants with genotype results carried the CYP2B6:983 T/C genotype.

NigeriaVIH/sidapublié 2020Nigerian journal of clinical practicePubMeddocument de 8 observations

0,6 %HIV prevalence among young adolescents in Akwa Ibom State, Nigeria was 0.6%.

NigeriaVIH/sidaobservé 2017publié 2020BMC public healthPubMeddocument de 5 observations

0,44 %The HIV incidence rate in Akwa Ibom state, Nigeria, was 0.44% among participants aged 15 to 49 years in 2017.

NigeriaVIH/sidaobservé 2017publié 2021Journal of the International AIDS SocietyPubMeddocument de 9 observations

2,95 correct_responsesThe mean number of correct HIV-related knowledge responses increased to 2.95 after 9 months in the study among MSM and TGW in Nigeria.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 6 observations

2,59 aORReporting of skin rashes/itching symptom was associated with higher likelihood of retention at 12 months (adjusted odds ratio = 2.59).

NigeriaVIH/sidapublié 2020Journal of the International Association of Providers of AIDS CarePubMeddocument de 6 observations

96,8 %The 28-day mean adherence level to HAART was 96.8% among adult PLHIVs attending a tertiary hospital in Nigeria.

NigeriaVIH/sidapublié 2020Ghana medical journalPubMeddocument de 7 observations

0,22 %Among 2775 pregnant women in Nigeria, the seroprevalence of HIV-HBV dual infection was 0.22%.

Nigeriahépatite B · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

52,7 %Self-reported HIV status had a sensitivity of 52.7% (95% confidence interval: 49.4%–56.0%) and specificity of 99.9% (95% confidence interval: 99.8%–99.9%) in NAIIS.

NigeriaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations

97,3 %Among 1504 enrolled HIV-positive adults in Nigeria, 1463 (97.3%) were on antiretroviral therapy.

NigeriaVIH/sidaobservé April 2016 to April 2017publié 2019The Nigerian postgraduate medical journalPubMeddocument de 6 observations

39,9 %Among 2652 TB/HIV co-infected patients in seven PEPFAR-supported states in Nigeria, TB treatment success was observed in 39.9% (cured) and 44.7% (completed).

Nigeriatuberculose · VIH/sidapublié 2024The Pan African medical journalPubMeddocument de 5 observations

29,8 %Among 57 HIV-infected, HIV-exposed infants in Plateau State, Nigeria, 29.8% (17/57) experienced treatment mortality or losses (TX_ML).

NigeriaVIH/sidaobservé 2018–2022publié 2026PloS onePubMeddocument de 13 observations

3,2 %Human Immunodeficiency Virus was the second leading indirect cause of maternal mortality, accounting for 3.2% of cases.

NigeriaVIH/sidaobservé 2007-2019publié 2022BMC pregnancy and childbirthPubMeddocument de 10 observations

70,5 %70.5% of 498 participants were living with HIV.

NigeriaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 6 observations

35 %In 2017, only 35% of children aged 0–14 years living with HIV in Nigeria had been diagnosed and were receiving antiretroviral therapy.

NigeriaVIH/sidaobservé 2017publié 2020PloS onePubMeddocument de 16 observations

2,1 odds_ratioHIV-exposed infants tested at 6–8 weeks of age had significantly greater odds of a negative HIV result (OR = 2.1) compared to those tested after 20 weeks of age in North-Central Nigeria from January 2015 through July 2017.

NigeriaVIH/sidaobservé January 2015 through July 2017publié 2019AIDS research and therapyPubMeddocument de 8 observations

9 %About 9% of all persons living with HIV infection (PLWH) worldwide were resident in Nigeria as of 2014.

NigeriaVIH/sidaobservé 2014publié 2023West African journal of medicinePubMeddocument de 11 observations

25,3 %Among 641 participants in Lagos state, Nigeria, 162 (25.3%) were living with HIV.

NigeriaVIH/sidaobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations

1 600 000 deathsOver 1.6 million Nigerians have succumbed to AIDS since its discovery.

NigeriaVIH/sidapublié 2024Annals of African medicinePubMeddocument de 12 observations

15,4 %HIV prevalence was 15.4%–23.9% at highway settlements in Nigeria.

NigeriaVIH/sidaobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations

Patients with HIV on HAART have thicker optic nerves compared with the general population in Kano, Nigeria.

NigeriaVIH/sidaobservé October 2017 to June 2018publié 2019Nigerian journal of clinical practicePubMeddocument de 5 observations

57,6 %There were 1993 prevalent cases of delayed HIV diagnosis among 3458 HIV patients, representing 57.6%.

NigeriaVIH/sidapublié 2022International journal of STD & AIDSPubMeddocument de 4 observations

3 326 servicesThe average annual number of HIV counseling and testing (HCT) services provided per community-based organization (CBO) in Nigeria was 3,326.

NigeriaVIH/sidaobservé 2016publié 2023PloS onePubMeddocument de 10 observations

9,3 %The missed opportunity for HIV testing among antenatal care attendees in Nigeria was 9.3% overall in 2019.

NigeriaVIH/sidaobservé 2019publié 2023AIDS carePubMeddocument de 7 observations

76,8 %The seroprevalence of herpes simplex virus (HSV)-1 among patients with HIV in Nigeria was 76.8%.

Nigeriaherpes simplex virus (HSV)-1 · VIH/sidaobservé 2019publié 2023BMJ openPubMeddocument de 5 observations